欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1186/002
药品名称Righla 5 mg
活性成分
    • APIXABAN 5.0 mg
剂型Film-coated tablet
上市许可持有人Adalvo Limited Malta Life Sciences Park, Building 1, Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate SGN 3000 San Gwann Malta
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Czechia (CZ)
      Righla
    • Germany (DE)
      Righla 5 mg Filmtabletten
    • Netherlands (NL)
      Sewab 5 mg filmomhulde tabletten
许可日期2024/05/23
最近更新日期2024/08/03
药物ATC编码
    • B01AF02 apixaban
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase